Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increased CDA expression/activity in males contributes to decreased cytidine analog half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapy.
Mahfouz RZ, Jankowska A, Ebrahem Q, Gu X, Visconte V, Tabarroki A, Terse P, Covey J, Chan K, Ling Y, Engelke KJ, Sekeres MA, Tiu R, Maciejewski J, Radivoyevitch T, Saunthararajah Y. Mahfouz RZ, et al. Among authors: tiu r. Clin Cancer Res. 2013 Feb 15;19(4):938-48. doi: 10.1158/1078-0432.CCR-12-1722. Epub 2013 Jan 3. Clin Cancer Res. 2013. PMID: 23287564 Free PMC article.
Updates in cytogenetics and molecular markers in MDS.
Tiu RV, Visconte V, Traina F, Schwandt A, Maciejewski JP. Tiu RV, et al. Curr Hematol Malig Rep. 2011 Jun;6(2):126-35. doi: 10.1007/s11899-011-0081-2. Curr Hematol Malig Rep. 2011. PMID: 21340513 Review.
Clofarabine for myelodysplastic syndromes.
Tiu RV, Traina F, Sekeres MA. Tiu RV, et al. Expert Opin Investig Drugs. 2011 Jul;20(7):1005-14. doi: 10.1517/13543784.2011.585967. Epub 2011 May 19. Expert Opin Investig Drugs. 2011. PMID: 21591997 Review.
Blood consult: treating del(5q) myelodysplastic syndromes.
Mukherjee S, Tiu RV, Sekeres MA. Mukherjee S, et al. Blood. 2012 Jan 12;119(2):342-4. doi: 10.1182/blood-2011-09-376103. Epub 2011 Oct 28. Blood. 2012. PMID: 22039258 Free article. No abstract available.
Clonal evolution in aplastic anemia.
Afable MG 2nd, Tiu RV, Maciejewski JP. Afable MG 2nd, et al. Hematology Am Soc Hematol Educ Program. 2011;2011:90-5. doi: 10.1182/asheducation-2011.1.90. Hematology Am Soc Hematol Educ Program. 2011. PMID: 22160018 Review.
A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF).
Bejanyan N, Tiu RV, Raza A, Jankowska A, Kalaycio M, Advani A, Chan J, Saunthararajah Y, Mooney L, Maciejewski JP, Sekeres MA. Bejanyan N, et al. Cancer. 2012 Aug 15;118(16):3968-76. doi: 10.1002/cncr.26741. Epub 2011 Dec 16. Cancer. 2012. PMID: 22180010 Free article. Clinical Trial.
135 results